1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Erectile Dysfunction-Pipeline Insights, 2016

Erectile Dysfunction-Pipeline Insights, 2016

  • November 2016
  • -
  • Delve Insight
  • -
  • 60 pages


DelveInsight’s, “ Erectile Dysfunction-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Erectile Dysfunction. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Erectile Dysfunction. DelveInsight’s Report also assesses the Erectile Dysfunction therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.

Scope
- The report provides competitivepipeline landscape of Erectile Dysfunction
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Erectile Dysfunction pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Erectile Dysfunction and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Table Of Contents

Erectile Dysfunction-Pipeline Insights, 2016

Illustrative Table of contents

- Erectile Dysfunction Overview
- Erectile Dysfunction Pipeline Therapeutics
- Erectile Dysfunction Therapeutics under Development by Companies
- Erectile Dysfunction Filed and Phase III Products
- Comparative Analysis
- Erectile Dysfunction Phase II Products
- Comparative Analysis
- Erectile Dysfunction Phase I and IND Filed Products
- Comparative Analysis
- Erectile Dysfunction Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Erectile Dysfunction - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Erectile Dysfunction - Discontinued Products
- Erectile Dysfunction - Dormant Products
- Companies Involved in Therapeutics Development for Erectile Dysfunction
- Appendix
- Methodology
- Contact Us
- Disclaimer

List of Tables

- Number of Products under Development for Erectile Dysfunction, 2016
- Number of Products under Development by Companies
- Comparative Analysis by Filed and Phase III Products, 2016
- Comparative Analysis Phase II Products, 2016
- Comparative Analysis Phase I and IND Filed Products, 2016
- Comparative Analysis Discovery and Pre-Clinical Stage Products, 2016
- Drug Candidates Profiles
- Erectile Dysfunction Assessment by Monotherapy Products
- Erectile Dysfunction Assessment by Combination Products
- Erectile Dysfunction Assessment by Route of Administration
- Erectile Dysfunction Assessment by Stage and Route of Administration
- Erectile Dysfunction Assessment by Molecule Type
- Erectile Dysfunction Assessment by Stage and Molecule Type
- Erectile Dysfunction Therapeutics - Discontinued Products
- Erectile Dysfunction Therapeutics - Dormant Products
- Products under Development by Companies, 2016

List of Figures

- Number of Products under Development for Erectile Dysfunction, 2016
- Filed and Phase III Products, 2016
- Phase II Products, 2016
- Phase I and IND Filed Products, 2016
- Discovery and Pre-Clinical Stage Products, 2016
- Erectile Dysfunction Assessment by Monotherapy Products
- Erectile Dysfunction Assessment by Combination Products
- Erectile Dysfunction Assessment by Route of Administration
- Erectile Dysfunction Assessment by Stage and Route of Administration
- Erectile Dysfunction Assessment by Molecule Type
- Erectile Dysfunction Assessment by Stage and Molecule Type

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Erectile Dysfunction  - Market Insights, Epidemiology and Market Forecast-2023

Erectile Dysfunction  - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Erectile Dysfunction - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and ...

Global Erectile Dysfunction Drugs Market Report 2016

Global Erectile Dysfunction Drugs Market Report 2016

  • $ 2850
  • Industry report
  • August 2016
  • by 9Dimen Research

2016 Global Erectile Dysfunction Drugs Report is a professional and in-depth research report on the world's major regional market conditions of the Erectile Dysfunction Drugs industry, focusing on the ...

Erectile Dysfunction  - Epidemiology Forecast To 2023

Erectile Dysfunction  - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight “Erectile Dysfunction  - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Erectile Dysfunction  in seven major markets (US, France, Germany, Italy, Spain, ...


Download Unlimited Documents from Trusted Public Sources

Opioid and Dysfunction Drug Market in Canada

  • October 2016
    71 pages
  • Opioid  

    Dysfunction Dru...  

  • Canada  

View report >

Dysfunction Drug Market and Genitourinary System Disease Statistics in the UK

  • August 2016
    15 pages
  • Dysfunction Dru...  

    Genitourinary S...  

    Dermatological ...  

  • United Kingdom  

View report >

Hormone and Therapy Market in the US

  • July 2016
    8 pages
  • Hormone  

    Therapy  

    Prostate Cancer  

  • United States  

View report >

Therapy Market In The Us

11 months ago

Therapy Market In Israel

11 months ago

Related Market Segments :

Dysfunction Drug

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.